CoChat

Metabolic Obesity Phenotypes and Risk of Breast Cancer in Postmenopausal Women

Open access
Kabat, Geoffrey C., Kim, Mimi Y., Lee, Jennifer S., Ho, Gloria Y., Going, Scott B., Beebe-Dimmer, Jennifer, Manson, JoAnn E., Chlebowski, Rowan T., Rohan, Thomas E. · 2017 · Cancer Epidemiology, Biomarkers & Prevention

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Abstract

Background: Obesity and the metabolic syndrome (MetS) have both been linked to increased risk of postmenopausal breast cancer; however, their relative contributions are poorly understood. Methods: We examined the association of metabolic phenotypes of obesity defined by presence of the MetS (yes and no) and body mass index (BMI; normal, overweight, obese) with risk of postmenopausal breast cancer in a prospective analysis of a cohort of postmenopausal women (n ∼ 21,000) with baseline measurements of blood glucose, triglycerides, HDL-cholesterol, blood pressure, waist circumference, and BMI. Women were classified into 6 metabolic obesity phenotypes according to their BMI (18.5–<25.0, 25.0–<30.0, ≥30.0 kg/m2) and presence of the MetS (≥3 of the following: waist circumference ≥88 cm, triglycerides ≥150 mg/dL, HDL-C <50 mg/dL, glucose ≥100 mg/dL, and systolic/diastolic blood pressure ≥130/85 mmHg or treatment for hypertension). HRs for incident breast cancer and 95% confidence intervals (95% CI) were estimated using Cox proportional hazards models. Results: Over 15 years of follow-up, 1,176 cases of invasive breast cancer were diagnosed. Obesity, regardless of metabolic health, was associated with increased risk of breast cancer. Being obese and metabolically unhealthy was associated with the highest risk: HR, 1.62; 95% CI, 1.33–1.96. These associations were stronger in women who had never used hormone therapy. Conclusions: Our findings suggest that both obesity and metabolic dysregulation are associated with breast cancer risk. Impact: Beyond BMI, metabolic health should be considered a clinically relevant and modifiable risk factor for breast cancer. Cancer Epidemiol Biomarkers Prev; 26(12); 1730–5. ©2017 AACR.

Overview

Integrity signals

Registry

Crossref · 10.1158/1055-9965.epi-17-0495

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 33 references

Cited by

See all 143

Metadata

Authors
Kabat, G. C., Kim, M. Y., Lee, J. S., Ho, G. Y., Going, S. B., Beebe-Dimmer, J., Manson, J. E., Chlebowski, R. T., & Rohan, T. E.
Affiliations
  • Albert Einstein College of Medicine (US)
  • VA Palo Alto Health Care System (US)
  • Feinstein Institute for Medical Research (US)
  • University of Arizona (US)
  • 6Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan.
  • Brigham and Women's Hospital (US)
  • City Of Hope National Medical Center (US)
Corresponding author
Kabat, Geoffrey C.
Venue
Cancer Epidemiology, Biomarkers & Prevention
Published
2017-11-30
Volume
26
Issue
12
Pages
1730-1735
ISSN
  • 1055-9965 (ISSN-L)
  • 1538-7755
OpenAlex
W2758760080
Cited by
136
References
33
Citations by year
2026: 7 · 2025: 3 · 2024: 10 · 2023: 25 · 2022: 37 · 2021: 26 · 2020: 16 · 2019: 5 · 2018: 7
FWCI
3.38
Type
journal article
Language
en
Open access
Locations
  • Cancer Epidemiology Biomarkers & Prevention (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Cancer Institute (P30CA022453)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Risks and Factors
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
Keywords
postmenopausal breast cancer, obesity, metabolic syndrome, body mass index, metabolic health, hormone therapy, breast cancer risk factors, metabolic dysfunction
MeSH terms
Aged, Breast Neoplasms, Calcium, Female, Humans, Middle Aged, Obesity, Phenotype, Prospective Studies, Risk Factors, United States, Vitamin D, Body Mass Index, Prevalence, Postmenopause, Diet, Fat-Restricted, Antineoplastic Agents, Hormonal, Metabolic Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metabolic Obesity Phenotypes and Risk of Breast Cancer in Postmenopausal Women. https://app.cochat.ai/papers/10.1158/1055-9965.epi-17-0495
The paper
Kabat, G. C., Kim, M. Y., Lee, J. S., Ho, G. Y., Going, S. B., Beebe-Dimmer, J., Manson, J. E., Chlebowski, R. T., & Rohan, T. E. (2017). Metabolic Obesity Phenotypes and Risk of Breast Cancer in Postmenopausal Women. Cancer Epidemiology, Biomarkers & Prevention. https://doi.org/10.1158/1055-9965.epi-17-0495

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.